Research Autoinjectable PCSK9 Inhibitor; Caution on CoQ10; Ohio Doc’s Rape ChargesBy Healthcare Propulsion StaffAugust 19, 20260 The FDA approved the autoinjector version of lerodalcibep (Lerochol), a PCSK9 inhibitor for LDL cholesterol lowering, LIB Therapeutics announced. Bracco…
Research Neurocrine stands by blockbuster hopeful Vykat XR as Prader-Willi docs raise potential safety flagsBy Healthcare Propulsion StaffAugust 13, 20260 Roughly a year and a half after the approval of Vykat XR, a group of clinicians with deep ties to…
